XML 146 R128.htm IDEA: XBRL DOCUMENT v3.20.4
Selected Quarterly Financial Data (Unaudited) - Selected Quarterly Financial Data (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Selected Quarterly Financial Information [Line Items]                      
Net revenues $ 4,454 $ 3,978 $ 3,870 $ 4,357 $ 4,468 $ 4,093 $ 4,177 $ 4,149 $ 16,659 $ 16,887 $ 18,271
Gross profit 2,048 1,852 1,763 2,063 1,958 1,830 1,893 1,856 7,726 7,537 8,296
Net income (loss) 162 (4,340) 53 25 75 (307) (671) (97) (4,099) (1,000) (2,472)
Net income (loss) attributable to Teva 150 (4,349) 140 69 110 (314) (689) (105) (3,990) (999) (2,150)
Net income (loss) attributable to ordinary shareholders $ 150 $ (4,349) $ 140 $ 69 $ 110 $ (314) $ (689) $ (105) $ (3,990) $ (999) $ (2,399)
Earnings per share attributable to ordinary shareholders:                      
Basic $ 0.14 $ (3.97) $ 0.13 $ 0.06 $ 0.10 $ (0.29) $ (0.63) $ (0.10) $ (3.64) $ (0.91) $ (2.35)
Diluted $ 0.14 $ (3.97) $ 0.13 $ 0.06 $ 0.10 $ (0.29) $ (0.63) $ (0.10) $ (3.64) $ (0.91) $ (2.35)